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Abstract Cardiac enzyme release is common after
percutaneous coronary intervention (PCI). At present
there is no established relationship between the
quantity of necrotic core and dense calcium, as
assessed by Shin’s method using intravascular ultra-
sound virtual histology (VH-IVUS), and post-PCI
creatinine kinase-MB (CK-MB) elevation. A total of
112 consecutive patients with unstable angina and a
normal pre-PCI CK-MB level were imaged using VH-
IVUS. Patients were divided into 2 groups according to
the presence (CK-MB group, n = 22) or absence (non
CK-MB group, n = 90) of a post-PCI CK-MB eleva-
tion [1.0 the upper limit of normal (3.6 ng/ml). Using
Shin’s method contours were drawn around the IVUS
catheter (instead of the lumen), and the vessel. Mean
area and volume of necrotic core and dense calcium
were significantly greater in CK-MB group than in non
CK-MB group (1.7 ± 0.9 mm2 vs. 0.9 ± 0.6 mm2,
P \ 0.001; 17.2 ± 8.8 mm3 vs. 8.8 ± 5.8 mm3, P \
0.001, and 0.9 ± 0.6 mm2 vs. 0.4 ± 0.4 mm2, P =
0.001; 9.1 ± 5.8 mm3 vs. 3.9 ± 3.7 mm3, P \ 0.001,
respectively). Percent necrotic core and dense calcium
areas calculated by external elastic membrane (EEM)
area were significantly greater in CK-MB group than in
non CK-MB group (11.9 ± 5.1 vs. 6.6 ± 4.0%,
P \ 0.001 and 6.5 ± 4.0 vs. 3.0 ± 2.9%, P \ 0.001,
respectively). In the multivariate analysis, dense
calcium volume and percent necrotic core to EEM at
the most diseased segment were the only independent
predictors of post-PCI CK-MB elevation (odds ratio:
1.22; 95% confidence interval: 1.09–1.37, P \ 0.001
and odds ratio: 1.26; 95% confidence interval:
1.12–1.43, P \ 0.001). Lesions with a greater amount
of dense calcium volume and percent necrotic core to
EEM, which can be easily identified and quantified on
VH-IVUS analyzed using Shin’s method, are respon-
sible for post-PCI CK-MB elevation. With a rapid
analyzing time, Shin’s method may increase the
identification of high risk lesions likely to induce a
post-procedural myocardial injury in the catheteriza-
tion laboratory facilitating on-line clinical decision
making.
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Introduction
Myocardial necrosis as indicated by an elevation of
creatinine kinase-myoglobin band (CK-MB) occurs
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in 5–30% of patients following percutaneous coronary
intervention (PCI), and is associated with increased
mortality even following low rises in CK-MB [1–3].
CK-MB elevation after PCI has been seen linked with
side-branch occlusion, thrombus formation, a large
atherosclerotic plaque burden as assessed by intra-
vascular ultrasound (IVUS) and an aggressive inter-
ventional procedure [4, 5]. A recent study has
indicated that a significant relationship exists
between plaque components, notably necrotic core,
and cardiac enzyme elevation after PCI [6]. Although
IVUS Virtual Histology (VH-IVUS) has demon-
strated its utility in quantifying coronary plaque
components with a high predictive accuracy both in
vitro and in vivo [7, 8], it is used infrequently in the
catheterization laboratory for the purpose of clinical
decision making, which is partly because it is not
easy to immediately draw the contours required for
analysis. Shin’s method for the analysis of VH-IVUS
images is described elsewhere; in brief, the method
entails drawing the contour of the IVUS catheter
instead of the lumen contour, and it is therefore
suitable for the measurement of necrotic core and
dense calcium. Shin’s method is well correlated with
the conventional methods employed to measure
necrotic core and calcium, and beneficially has a
significantly shorter analysis time [9]. The purpose of
the present study was to investigate the relationship
of pre-PCI necrotic core and calcium content, as
determined using VH-IVUS and Shin’s method, to
CK-MB elevation after PCI.
Methods
Study population
This study was conducted in a single Korean center,
and enrolled 112 consecutive patients with unstable
angina, who had a normal CK-MB level on admis-
sion, underwent pre-PCI VH-IVUS and had success-
ful elective coronary artery stenting to a single,
native, de novo coronary lesion. All patients had
unstable angina, defined as new-onset severe angina,
accelerated angina, or angina at rest without ST
segment elevation in the ECG. Successful coronary
artery stenting was defined as a final residual
diameter stenosis \30% on visual assessment and
normal distal coronary flow at the end of the
procedure. Patients with an elevated baseline pre-
PCI CK-MB, a side branch occlusion originating
from a stented segment after PCI, or intracoronary
thrombus in the target vessel on angiography or IVUS
before and after PCI, were excluded. Other exclu-
sions included patients presenting with acute myo-
cardial infarction, patients who had left main disease,
chronic total occlusions, patients with impaired left
ventricular function on echocardiography, and those
who required multi-vessel PCI and/or use of an
atherectomy device. All patients received aspirin
(100–200 mg) and clopidogrel (300 mg) for at least
24 h before PCI. All patients provided written
informed consent and the study was approved by
the hospital’s institutional review board.
CK-MB analysis
Venous blood samples were obtained from all
patients at admission, 1 h before PCI, and at eight
hourly intervals for 24 h post PCI. The upper normal
cutoff value for CK-MB according to the assay used
in all patients was 3.6 ng/ml. After PCI, patients were
divided into 2 groups: post-PCI CKMB [1 the upper
limit of normal (CK-MB group) versus post-PCI
CKMB B1 the upper limit of normal (non CK-MB
group).
Angiographic analysis
All studies were reviewed by an experienced angi-
ographer who was blinded as to whether there was a
CK-MB elevation. Morphologic characteristics of
individual lesions were recorded, and the American
College of Cardiology/American Heart Association
(ACC/AHA) grading system was used to classify
lesions into types A, B, and C. Lesion length was
determined by callipers. Flow in the epicardial
coronary arteries was assessed using Thrombolysis
in Myocardial Infarction (TIMI) flow grade and the
corrected TIMI frame count [10, 11]. Side branch
occlusion was assessed thoroughly using side-by-side
analysis of cine loops before PCI, and of the final
result. Any angiographically visible side branch
likely to be directed toward the left ventricular
myocardium was considered; only atrial and right
ventricular arteries were excluded. Side branch
impairment was defined as any non-transient impair-
ment in flow, either TIMI 1 or TIMI 0 [12].
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VH-IVUS examination and analysis
All pre-PCI VH-IVUS examinations were performed
after intracoronary administration of 200 lg intra-
coronary nitroglycerin using a motorized transducer
pullback system (0.5 mm/s). The 2.9-F IVUS imag-
ing catheter (Eagle Eye, Volcano Corp., Rancho
Cordova, California) incorporated a 20-MHz phased-
array transducer. Off-line analyses were performed
using VH program software (Volcano Therapeutics,
Rancho Cordova, California) by an investigator who
was blinded to the patient’s clinical characteristics.
The VH-IVUS analysis classified and color-coded
tissue into 2 components: white (dense calcium), and
red (necrotic core) [8]. The region of interest
comprised of the most diseased 10-mm segment
within the culprit lesion that contained the largest
plaque burden. The culprit lesion was defined as the
coronary lesion thought responsible for the patient’s
symptoms and was treated with PCI. The external
elastic membrane (EEM) was measured, and percent
necrotic core and dense calcium areas or volumes to
EEM volume were calculated as necrotic core or
dense calcium areas or volumes divided by EEM
volume. The VH-IVUS analysis was reported as
absolute differences and as a percent necrotic core
and dense calcium to EEM.
Shin’s method for analysis of necrotic core
and dense calcium
Shin’s method also used the offline software pcVH 2.2.
Instead of measuring the lumen as described above for
the conventional method, in Shin’s method the lumen
contour is drawn around the IVUS catheter, that is,
without following the leading edge of the interface
lumen intima [9]. When there is a ‘‘flare’’ (ring-down
artifact) around the IVUS catheter, this catheter
contour must be drawn away from this flare (Fig. 1).
The catheter contour was manually detected.
Statistical analysis
All analyses were performed using SPSS (version
17.0; SPSS Inc, Chicago, Illinois). Discrete variables
were presented as percentages and relative frequen-
cies; comparisons were conducted by chi-square
statistics or Fisher exact test. Continuous variables
were presented as the mean ±1 SD; comparisons
were conducted by Student t test or nonparametric
Fig. 1 Comparison of intravascular ultrasound virtual histology images before coronary stenting in patients with CK-MB elevation
(A) and non CK-MB elevation (B)
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Wilcoxon test for normally and non-normally dis-
tributed data, respectively. A Spearman correlation
coefficient was used if the normality assumption
was not satisfied. Logistic regression analysis was
used to assess demographic, angiographic, procedural
and ultrasonographic characteristics associated with
CK-MB elevation. Variables with a significance
level \0.2 in the univariate analysis were considered
to be candidate variables for inclusion in the multi-
variable analysis and a step-down logistic regression
was performed. Only variables with a significance
level of \0.05 were retained in the final models.
Odds ratio and the associated 95% CIs were reported
for both the univariable and multivariable logistic
regression analyses. Statistical significance was
accepted as p less than 0.05.
Results
Table 1 shows the baseline characteristics of the
patients. Mean age of study subjects was 62 years;
CK-MB group was older than non CK-MB group.
Overall, 66 (59%) were male subjects. There were no
differences in levels of lipid or high sensitivity
C-reactive protein (hsCRP) between both groups. All
patients had taken aspirin and clopidogrel before PCI,
whilst Glycoprotein IIb/IIIa inhibitors were not used.
The peak CK-MB level was 16.7 ± 11.7 ng/ml in
CK-MB group and 1.9 ± 1.1 mg/ml in non CK-MB
group.
Angiographic findings and procedural results
Table 2 shows the angiographic findings and proce-
dural results. The studied vessel was the left anterior
descending artery in 66 patients (58.9%), the left
circumflex artery in 14 (12.5%) and the right
coronary artery in 32 (28.6%). There were more
patients with ACC/AHA Type B2 and C lesions in
CK-MB group compared with non CK-MB group
(86.4 vs. 64.4%, P = 0.07). All lesions were treated
with stent implantation: 75 lesions with sirolimus-
eluting stents, 2 lesion with paclitaxel-eluting stent,
Table 1 Baseline
characteristics
Values are presented as











CK-MB (n = 22) Non CK-MB (n = 90) P
Age, years 65.5 ± 8.3 61.4 ± 8.3 0.06
Male 11 (50) 55 (61.1) 0.35
History
Previous MI 2 (9.1) 4 (4.4) 0.34
Previous PCI 3 (13.6) 17 (18.9) 0.76
Previous CABG 2 (9.1) 1 (1.1) 0.1
Risk factors
Hypertension 16 (72.7) 46 (51.1) 0.09
Hypercholesterolemia 14 (63.6) 48 (53.3) 0.48
Diabetes mellitus 5 (22.7) 29 (32.2) 0.45
Current smoking 1 (4.5) 23 (25.6) 0.04
Previous statin use 6 (27.3) 19 (21.1) 0.57
Before PCI aspirin use 22 (100) 90 (100) [0.99
Before PCI clopidogrel use 22 (100) 90 (100) [0.99
Glycoprotein IIb/IIIa inhibitor use 0 0
Ejection fraction, % 63.5 ± 5.3 63.4 ± 7.1 0.92
Total cholesterol, mg/dl 192.9 ± 39.3 189.0 ± 43.3 0.70
Triglyceride, mg/dl 132.9 ± 55.1 151.5 ± 82.5 0.32
HDL cholesterol, mg/dl 40.6 ± 6.1 42.1 ± 13.9 0.63
LDL cholesterol, mg/dl 116.6 ± 33.4 106.3 ± 36.7 0.63
Serum creatinine, mg/dl 1.04 ± 0.12 1.11 ± 0.55 0.53
hsCRP, mg/L 2.0 ± 3.1 1.8 ± 3.6 0.83
Peak CKMB, ng/ml 16.7 ± 11.7 1.9 ± 1.1 \0.001
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18 lesions with everolimus-eluting stents and 17
lesions with bare-metal stents. There was no signif-
icant difference between groups in the frequency of
side branches, the lesion length and degree of
stenosis. The size of balloon used for post-stenting
dilatation, and the maximum pressure used was
similar for both groups. No patients had a post-PCI
TIMI flow grade 0/1, and post-PCI corrected TIMI
frame count was not significantly different between
groups (16.0 ± 7.3 vs. 12.6 ± 5.1, P = 0.07).
IVUS results
Table 3 shows the geometrical and compositional
findings. Patients in both groups had a comparable
plaque burden (67.1 ± 7.8% in CK-MB group and
66.2 ± 8.3% in non CK-MB group, P = 0.63), mean
EEM area and remodeling index. The mean necrotic
core and dense calcium area were significantly
greater in CK-MB group (Fig. 2). In addition, the
necrotic core and dense calcium volumes were
significantly greater in the CK-MB group than in
the non CK-MB group. Percent necrotic core area and
volume, and percent dense calcium area and volume
to EEM were also significantly greater in the CK-MB
group compared to the non CK-MB group. A




Values are presented as
number (%) or mean ± SD.
LAD left anterior
descending artery, LCX left
circumflex artery, RCA right
coronary artery
CK-MB (n = 22) Non CK-MB (n = 90) P
Study vessel
LAD 11 (50) 55 (61.1) 0.35
LCX 5 (22.7) 9 (10) 0.15
RCA 6 (27.3) 26 (28.9) [0.99
Lesion type, B2 and C 19 (86.4) 58 (64.4) 0.07
Side branch 14 (63.6) 54 (60.0) 0.81
Lesion length, mm 26.5 ± 19.9 24.2 ± 17.5 0.59
Degree of stenosis 63.1 ± 19.9 59.8 ± 17.9 0.46
Stent type 0.65
Sirolimus-eluting stent 13 (59.1) 62 (68.9)
Paclitaxel-eluting stent 0 2 (2.2)
Everolimus-eluting stent 5 (22.7) 13 (14.4)
Bare-metal stent 4 (18.2) 13 (14.4)
Number of stents 1.6 ± 0.6 1.3 ± 0.6 0.11
Stent diameter, mm 3.3 ± 0.3 3.4 ± 0.3 0.23
Stent length, mm 32.8 ± 16.3 30.9 ± 18.8 0.62
Stent-balloon maximum pressure, atm 14.1 ± 3.1 15.1 ± 3.4 0.19
Post-stent balloon use 19 (86.4) 72 (80) 0.76
Post-stent balloon size, mm 3.6 ± 0.4 3.9 ± 0.5 0.46
Post-stent balloon maximum pressure, atm 17.2 ± 1.9 16.9 ± 3.0 0.64
Post-PCI TIMI flow grade 0/1 0 0
Post-PCI corrected TIMI frame count 16.0 ± 7.3 12.6 ± 5.1 0.07






Remodelling index 1.1 ± 0.3 1.0 ± 0.2 0.16
Volumetric analysis, mm3
EEM 143.2 ± 37.5 137.2 ± 33.1 0.46
Dense calcium 9.1 ± 5.8 3.9 ± 3.7 \0.001
Necrotic core 17.2 ± 8.8 8.8 ± 5.8 \0.001
Mean area, mm2
EEM 14.1 ± 3.7 13.6 ± 3.2 0.48
Dense calcium 0.9 ± 0.6 0.4 ± 0.4 0.001
Necrotic core 1.7 ± 0.9 0.9 ± 0.6 \0.001
Percent area to EEM, %
Dense calcium 6.5 ± 4.0 3.0 ± 2.9 \0.001
Necrotic core 11.9 ± 5.1 6.6 ± 4.0 \0.001
Values are presented mean ± SD. EEM external elastic
membrane
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Correlations to peak CK-MB level
The peak CK-MB level correlated with: (1) necrotic
core volume (r = 0.438, P \ 0.001) and mean necro-
tic core area (r = 0.428, P \ 0.001); (2) dense calcium
volume (r = 0.414, P \ 0.001) and mean dense
calcium area (r = 0.428, P \ 0.001) (3) percent
necrotic core area to EEM (r = 0.384, P \ 0.001);
(4) percent dense calcium area to EEM (r = 0.358,
P \ 0.001) at the most diseased segment (Fig. 3).
Independent predictors of post-PCI CK-MB
elevation
Demographic, angiographic, procedural and ultraso-
nographic variables as they relate to CK-MB eleva-
tion are shown in Table 4. Those variables that were
independently predictive of CK-MB elevation are
shown in Table 5. Dense calcium volume and percent
necrotic core to EEM were the only independent
predictors of post-PCI CK-MB elevation (odds ratio:
1.22; 95% confidence interval: 1.09–1.37, P = 0.001
and odd ratio: 1.26; 95% confidence interval:
1.12–1.43, P \ 0.001). The area under the receiver-
operator characteristic curve for percent necrotic core
area to EEM at the most diseased segment predicting
post-PCI CK-MB elevation [1 the upper limit of
normal was 0.791 (Fig. 4).
Discussion
The present study is the first report to demonstrate
that necrotic core and dense calcium measured by
Shin’s method using pre-PCI VH-IVUS is associated
with post-PCI CK-MB elevation. CK-MB elevation
post PCI has been validated as a marker of short- and
long-term prognosis [2, 13–15]. The most common
definition of peri-procedural MI is a CK-MB eleva-
tion C3 times the upper limit of normal, however, this
is only an arbitrary cutoff [3]. A recent study showed
that the lack of substantial agreement between cardiac
enzymes and late gadolinium enhancement by cardiac
MRI for the diagnosis of small-sized periprocedural
myocardial damage after PCI [16]. However, contrast
enhanced MRI has demonstrated that even low levels
of CK-MB elevation can correspond to discrete areas
of micro-infarction [17]. Alternatively, even small,
asymptomatic elevations of CK-MB have been clearly
associated with a poorer long-term outcome [1, 18,
19]. The aim of the current study was to demonstrate
the association between CK-MB elevation and plaque
composition, and therefore those patients with
other factors known to increase CK-MB levels such
as side-branch occlusion, intracoronary thrombus and
no-reflow after stent implantation were excluded.
Recently, several studies have shown the relationship
between VH-IVUS findings and post-PCI distal
embolization. Kawaguchi et al. studied high-risk
plaque and distal embolization after stent deployment
in patients with acute ST-segment elevation myocar-
dial infarction with VH-IVUS. Results showed
that the volume of necrotic core clearly predicted
ST-segment re-elevation, which was used as a surro-
gate to evaluate distal embolization in this study after
stent deployment [20]. Kawamoto et al. studied the
relationship between coronary plaque components
and the small embolic particles produced during
stenting, and also examined the influence of this on
the coronary microcirculation using VH-IVUS. They
Fig. 2 Comparisons of mean necrotic core and dense calcium areas before coronary stenting with CK-MB elevation and non CK-MB
elevation
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showed that the necrotic core component was related
to liberation of small embolic particles during coro-
nary stenting, which resulted in the poorer recovery
of coronary flow reserve velocity [21]. Although
VH-IVUS may play an important role in detecting
which lesions are at high risk for myocardial necrosis
after PCI, it is not used routinely in the catheterization
laboratory for clinical decision making, which is
partly because it is not easy to immediately draw
the contours. In particular, lumen contour detection
takes a long time and it is especially challenging in
patients with high risk lesions (i.e., acute coronary
syndrome) because there is no clear separation
between luminal thrombi and intima [9]. Shin’s
method is well correlated with conventional methods
for the measurement of necrotic core and calcium
content, whilst also being significantly quicker to
perform [9]. In the present study, post-PCI CK-MB
elevation occurred in lesions with a large dense
calcium volume and percent necrotic core area to
EEM at the most diseased 10 mm segment of the
lesion. The CK-MB elevation correlated with necrotic
core volume and area, dense calcium volume and area,
percent necrotic core area and percent dense calcium
area to EEM at the most diseased segment. In the
multivariate analysis, dense calcium volume and
percent necrotic core area to EEM at the most
diseased segment were the only independent
Fig. 3 Correlations of CK-
MB level and A necrotic
core volume, B dense
calcium volume, C mean
necrotic core area, D mean
dense calcium area,
E percent necrotic core area
to EEM, F percent dense
calcium area to EEM (EEM
external elastic membrane)
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predictors of post-PCI CK-MB elevation (odds ratio:
1.22; 95% confidence interval: 1.09–1.37, P = 0.001
and odd ratio: 1.26; 95% confidence interval:
1.12–1.43, P \ 0.001). Thus, Shin’s method may be
a useful modality for detecting lesions at risk for
myocardial necrosis during PCI.
Clinical implications
Post-PCI myonecrosis has been shown to be signif-
icantly reduced following the administration before
PCI of pharmacological treatments such as glycopro-
tein IIb/IIIa inhibitors [22–24] and statin therapy
[25], or the use of distal emboli protection devices
[26]. However, the precise indications for using




MB [ 3.6 ng/ml)
EEM external elastic
membrane
OR 95% CI P
Demographic
Age 1.05 0.10–1.10 0.08
Male 0.64 0.25–1.62 0.34
Previous MI 2.15 0.37–12.57 0.40
Previous PCI 0.68 0.18–2.56 0.57
Previous CABG 8.90 0.77–103.03 0.08
Hypertension 2.55 0.92–7.11 0.07
Hypercholesterolemia 1.50 0.57–3.92 0.41
Diabetes mellitus 0.62 0.21–1.84 0.39
Current smoking 0.14 0.02–1.09 0.06
Angiographic
Lesion type, B2 and C 3.49 0.96–12.72 0.06
Side branch 1.17 0.44–3.06 0.75
Lesion length 1.01 0.98–1.03 0.59
Degree of stenosis 1.01 0.98–1.04 0.46
Procedural
Number of stents 1.79 0.86–3.71 0.12
Stent-balloon maximum pressure 0.91 0.80–1.05 0.20
Post-stent balloon use 1.58 0.42–5.94 0.50
Post-stent balloon maximum pressure 1.04 0.86–1.25 0.71
Intravascular ultrasound
Remodelling index 5.26 0.52–53.17 0.16
EEM volume 1.01 0.99–1.02 0.45
Dense calcium volume 1.26 1.12–1.40 \0.001
Necrotic core volume 1.16 1.08–1.25 \0.001
Mean EEM area 1.05 0.91–1.21 0.47
Mean dense calcium area 10.22 3.29–31.74 \0.001
Mean necrotic core area 4.65 2.23–9.67 \0.001
Percent dense calcium to EEM 1.32 1.14–1.54 \0.001
Percent necrotic core to EEM 1.29 1.14–1.45 \0.001
Table 5 Multivariable predictors of CK-MB elevation (CK-
MB [ 3.6 ng/ml)
OR 95% CI P
Dense calcium volume 1.22 1.09–1.37 0.001
Percent necrotic core to EEM 1.26 1.12–1.43 \0.001
EEM external elastic membrane
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Measurement of necrotic core by Shin’s method
may increase the identification of those lesions likely
to induce a post-procedural myocardial injury, and
therefore indicate which lesions would benefit
most from these interventions for myocardial
protection.
Limitations
First, this study is based on a relatively small sample
size and arbitrary definition of post-PCI myocardial
injury. Second, diffuse atherosclerotic disease in the
target lesion are important factor affecting post-
procedural CK-MB elevation [5]. We did not eval-
uate total plaque volume in the target lesion and its
relationship with post-PCI CK-MB elevation. Third,
this was a retrospective single-center study. The
results of this study need to be verified by multi-
center, prospective studies. Lastly, Shin’s method
does not offer information about the location of the
necrotic core and dense calcium in relation to the
lumen.
Conclusions
Lesions with a higher content of dense calcium and
percent necrotic core to EEM, which can be easily
identified and quantified on VH-IVUS analyzed using
Shin’s method, are responsible for post-PCI CK-MB
elevation. With a shorter analysis time, Shin’s
method may increase the identification of high risk
lesions likely to induce a post-procedural myocardial
injury in the catheterization laboratory facilitating a
real-time clinical decision.
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